Glatiramer acetate – Boxed warning added
January 22, 2025 - The FDA announced that a Boxed Warning for the risk of anaphylaxis will be added to the labels of all glatiramer acetate containing products (e.g., Copaxone®, Glatopa®).
January 22, 2025 - The FDA announced that a Boxed Warning for the risk of anaphylaxis will be added to the labels of all glatiramer acetate containing products (e.g., Copaxone®, Glatopa®).